Literature DB >> 3878364

Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine.

A Tärnvik, M L Löfgren, S Löfgren, G Sandström, H Wolf-Watz.   

Abstract

The lymphocyte stimulation test was used to estimate specific cell-mediated immunity after vaccination with the live vaccine strain of Francisella tularensis. Nonvaccinated individuals and individuals vaccinated 1, 5 to 6, 7 to 8, and 9 years previously were tested. Lymphocytes from most vaccinees responded to an antigen preparation of the vaccine strain, and those vaccinated 9 years before testing responded to a similar extent as did vaccines in the other groups. A new technique was developed to study the presence of T lymphocytes among the stimulated cells. Stimulated cells were allowed to incorporate [14C]thymidine and were then fractionated into T and non-T lymphocytes. Most of the incorporation appeared in the fraction containing T lymphocytes. The data indicate that cell-mediated immunity endures for at least 9 years after vaccination with the live F. tularensis vaccine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878364      PMCID: PMC268460          DOI: 10.1128/jcm.22.4.527-530.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

Authors:  H T EIGELSBACH; C M DOWNS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

2.  Surface markers on human B and T lymphocytes. IV. Distribution of surface markers on resting and blast-transformed lymphocytes.

Authors:  M Jondal
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

3.  Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S E Holm
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

4.  Tularaemia in the rat. I. The cellular basis on host resistance to infection.

Authors:  A A Kostiala; D D McGregor; P S Logie
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

5.  Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis.

Authors:  A Tärnvik; S Löfgren
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

6.  Nature of "memory" in T-cell-mediated antibacterial immunity: anamnestic production of mediator T cells.

Authors:  R J North
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

7.  Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia.

Authors:  D S Burke
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

8.  Time of lymphocyte response after onset of tularemia and after tularemia vaccination.

Authors:  A Tärnvik; G Sandström; S Löfgren
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

9.  Infection-immunity in tularemia: specificity of cellular immunity.

Authors:  J L Claflin; C L Larson
Journal:  Infect Immun       Date:  1972-03       Impact factor: 3.441

10.  In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis.

Authors:  J E Nutter; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

View more
  11 in total

Review 1.  Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man.

Authors:  A Tärnvik; M Eriksson; G Sandström; A Sjöstedt
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  Kinetics of the immune response associated with tularemia: comparison of an enzyme-linked immunosorbent assay, a tube agglutination test, and a novel whole-blood lymphocyte stimulation test.

Authors:  Henrik Eliasson; Per Olcén; Anders Sjöstedt; Margareta Jurstrand; Erik Bäck; Sören Andersson
Journal:  Clin Vaccine Immunol       Date:  2008-06-18

3.  Interleukin 2 and gamma interferon production, interleukin 2 receptor expression, and DNA synthesis induced by tularemia antigen in vitro after natural infection or vaccination.

Authors:  R Karttunen; G Andersson; H P Ekre; K Juutinen; H M Surcel; H Syrjälä; E Herva
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

4.  Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia.

Authors:  A Johansson; L Berglund; U Eriksson; I Göransson; R Wollin; M Forsman; A Tärnvik; A Sjöstedt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Authors:  Kjell Eneslätt; Cecilia Rietz; Patrik Rydén; Svenja Stöven; Robert V House; Lawrence A Wolfraim; Arne Tärnvik; Anders Sjöstedt
Journal:  Eur J Immunol       Date:  2011-02-21       Impact factor: 5.532

6.  Francisella tularensis T-cell antigen identification using humanized HLA-DR4 transgenic mice.

Authors:  Jieh-Juen Yu; Tatareddy Goluguri; M Neal Guentzel; James P Chambers; Ashlesh K Murthy; Karl E Klose; Thomas G Forsthuber; Bernard P Arulanandam
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

7.  Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis.

Authors:  G Sandström; A Tärnvik; H Wolf-Watz
Journal:  J Clin Microbiol       Date:  1987-04       Impact factor: 5.948

8.  Transcriptome analysis of human immune responses following live vaccine strain (LVS) Francisella tularensis vaccination.

Authors:  Claudette L Fuller; Katherine C Brittingham; Mark W Porter; Matthew J Hepburn; Patricia L Petitt; Phillip R Pittman; Sina Bavari
Journal:  Mol Immunol       Date:  2007-03-08       Impact factor: 4.407

9.  Signatures of T cells as correlates of immunity to Francisella tularensis.

Authors:  Kjell Eneslätt; Monica Normark; Rafael Björk; Cecilia Rietz; Carl Zingmark; Lawrence A Wolfraim; Svenja Stöven; Anders Sjöstedt
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 10.  The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents.

Authors:  Julia A Tree; Helen Flick-Smith; Michael J Elmore; Caroline A Rowland
Journal:  J Immunol Res       Date:  2014-09-16       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.